Designing better antibody drugs with artificial intelligence

Nerve stimulation reduces pain and opioid use after orthopedic surgery
15 April 2021
Long-term survival rates for immunotherapies could be misinterpreted
15 April 2021

Designing better antibody drugs with artificial intelligence

Antibodies are not only produced by our immune cells to fight viruses and other pathogens in the body. For a few decades now, medicine has also been using antibodies produced by biotechnology as drugs. This is because antibodies are extremely good at binding specifically to molecular structures according to the lock-and-key principle. Their use ranges from oncology to the treatment of autoimmune diseases and neurodegenerative conditions.

Comments are closed.